Publication date: Sep 10, 2025
Admission to shared hospital rooms are a risk factor of healthcare-associated (HA) SARS-CoV-2. Quantifying the impact of engineering controls such as ventilation and filtration is essential to informing resource utilization and infection prevention guidelines. Multicenter test-negative study of patients exposed to SARS-CoV-2 in shared rooms across five hospitals between January and October, 2022. Independent variables tested were measured air changes per hour (ACH), presence of any room mechanical ventilation (RMV), or portable high-efficiency particulate air (HEPA) filter. Covariates included facility (number of beds in room, outbreak status of unit), source patient (presence of symptoms, RT-PCR cycle threshold (Ct) value), and exposed patient factors (age, sex, time from last SARS-CoV-2 vaccine, previous SARS-CoV-2 infection, exposure duration). Multilevel logistic mixed models used to estimate the impact of engineering controls on transmission. Among 468 exposed patients, secondary attack rate was 26. 3% (range 7. 5-33. 3% across hospitals). In multivariable analysis, increased ACH was associated with decreased odds of infection (adjusted odds ratio (aOR) 0. 88, 95% CI 0. 78-1. 00; p=. 046) as were exposure duration and Ct value of source patient. Presence of RMV was also associated with decreased odds of infection (aOR 0. 51, 95% CI 0. 27-0. 95; p=. 034) while use of portable HEPA filter was not significant (aOR 0. 58, 95% CI 0. 26-1. 31; p=. 18). Improved ventilation was independently associated with lower odds of SARS-CoV-2 infection among exposed roommates. Ensuring RMV is present and optimizing ACH may significantly mitigate the risk of HA-SARS-CoV-2. Future prospective studies should assess optimal ACH thresholds and the impact of portable HEPA filters.
| Concepts | Keywords |
|---|---|
| Attack | Ach |
| Healthcare | Cov |
| October | Exposed |
| Pcr | Hepa |
| Roommates | Infection |
| Odds | |
| Patient | |
| Portable | |
| Presence | |
| Risk | |
| Rmv | |
| Room | |
| Sars | |
| Transmission | |
| Ventilation |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | infection |
| drug | DRUGBANK | Medical air |
| drug | DRUGBANK | Acetylcholine |
| disease | IDO | facility |
| disease | MESH | SARS-CoV-2 infection |
| pathway | REACTOME | SARS-CoV-2 Infection |